NICE advises that metformin should not normally be started if estimated glomerular filtration rate (eGFR) is below 45 mL/min/1.73m unless the benefits are expected to outweigh the potential risks
M., Kim, W., Rouse, M
There are three major GLP-1 agonist medications on the market: Semaglutide Liraglutide Tirzepatide Well discuss the benefits of each and how they compare with each other
When the data of both the groups were combined, changes in d-ROMs were significantly correlated with HbA1c ( r = 0.338, p = 0.040), MGL ( r = 0.349, p = 0.034), SD ( r = 0.430, p = 0.008), MAGE ( r = 0.333, p = 0.044), CV ( r = 0.325, p = 0.050), TAR ( r = 0.373, p = 0.023), and TIR ( r = 0.404, p = 0.013) values in the univariate analysis
Compounded semaglutide was first introduced and patented in 2016, and FDA-approved as a type 2 diabetes treatment in 2017